Results 111 to 120 of about 12,312 (172)

Opportunistic Features of Non-<i>Clostridium botulinum</i> Strains Containing <i>bont</i> Gene Cluster. [PDF]

Pathogens
Grenda T, Grenda A, Jakubczyk A, Rybczyńska-Tkaczyk K.   +3 more
europepmc   +1 more source

A Six-Year Examination of the Influence of Surgical Technique and Intraoperative Intraglandular Clostridium Botulinum Toxin Application in Salivary Gland Tumor Operations. [PDF]

J Clin Med
Johnson F, Burian NM, Santer M, Strasser V, Steinbichler T, Hofauer B, Stenzl A, Klarer J, Lochbaum R, Lei H, Cao H, Hillebrand G, Bolooki A.   +12 more
europepmc   +1 more source

Harnessing the acceptor substrate promiscuity of Clostridium botulinum Maf glycosyltransferase to glyco-engineer mini-flagellin protein chimeras. [PDF]

Commun Biol
Sunsunwal S, Khairnar A, Subramanian S, Ramya TNC.   +3 more
europepmc   +1 more source

Alpha-1 antitrypsin inhibits Clostridium botulinum C2 toxin, Corynebacterium diphtheriae diphtheria toxin and B. anthracis fusion toxin. [PDF]

Sci Rep
Lietz S, Sokolowski LM, Barth H, Ernst K.   +3 more
europepmc   +1 more source

Repurposing FDA-approved disulfiram for targeted inhibition of diphtheria toxin and the binary protein toxins of Clostridium botulinum and Bacillus anthracis. [PDF]

Front Pharmacol
Borho J, Kögel M, Eckert A, Barth H.
europepmc   +1 more source

Closed genome sequence of Clostridium botulinum type B1 strain isolated from an infant botulism case in the United States. [PDF]

Microbiol Resour Announc
Pillai CA, Thirunavukkarasu N, Gonzalez-Escalona N, Melka D, Curry P, Binet R, Tallent S, Brown E, Sharma S.   +8 more
europepmc   +1 more source

Clostridium botulinum C3bot mediated effects on cytokine-induced psoriasis-like phenotype in full-thickness skin model. [PDF]

Naunyn Schmiedebergs Arch Pharmacol
Rohrbeck A, Bruhn VA, Hussein N, Hagemann S, Just I.   +4 more
europepmc   +1 more source